Darunavir CAS 206361-99-1

Arbidol CAS 131707-25-0
13/03/2020
Lopinavir CAS 192725-17-0
13/03/2020
Show all

Model: MOS 206361-99-1
Brand Name: MOSINTER
CAS No.: 206361-99-1
Molecular weight: 547.66
Molecular formula: C27H37N3O7S

Darunavir CAS 206361-99-1

Description:

Developed by tibotec, a subsidiary of Johnson & Johnson in the United States, it was first listed in the United

States in July 2006. The drug is used in combination with other antiretroviral drugs to treat adult patients with

human immunodeficiency virus (HIV) infection.

Specifications:

Items Specifications Results
Impurity at RRT1.3 ≤0.10% N.D
Individual impurity ≤0.50% 0.33%
Total impurities ≤1.0% 0.65%
Assay 97.0%~102.0% 99.60%
Conclusion It conforms to the above specification

Application:

Tirenavir is a new non peptide anti retroviral protease inhibitor used in AIDS treatment. It was first developed by

tibotec, an Icelandic branch of Johnson & Johnson pharmaceutical. It is the highest bioavailability of six protease

inhibitors (xaquinavir, litonavir, indenavir, nafinavir, enrenavir and abt378 / R) at present. It is released from the

surface of infected host cells by blocking The formation of new and mature virus particles can inhibit the protease

of virus and play a role. When the product is used for a long time, it can usually reduce the HIV vector in the blood,

increase the CD4 cell count, reduce the chance of HIV infection, improve the quality of life and prolong life. It is

suitable for adults who are infected with HIV but have no curative effect after taking existing antiretroviral drugs.

The drug must be used in combination with low-dose ritona chemical Book Wei or other antiretroviral preparations

to improve the efficacy. The antiviral activity in vitro can be evaluated by anti acute and chronic infected adult

lymphocytes and lymphocytes in peripheral blood. IC50 is 0.012-0.08mmol/l for acute infected cells and 0.41mmol/l

for chronic infected cells. Take orally, the recommended dose is 1200mg once, twice a day. The patients with mild to

moderate liver dysfunction and those with renal dysfunction should be reduced. The main adverse reactions of tirenavir

were gastrointestinal reactions, flushing, pruritus and numbness around the mouth, depression, mood disorder, taste disorder,

etc. This product is not recommended for patients with moderate to severe liver dysfunction. Because this component

contains sulfanilamide group, it is forbidden for those who are allergic to Sulfanilamide and those who are allergic

to any component in the prescription of this product.

Our strengths:

We can customize according to customer’s requirement.

If you have any question pls mail us or call us.

Reviews

There are no reviews yet.

Be the first to review “Darunavir CAS 206361-99-1”